Summary
Introduction

12
Interest in mitochondrial biology is on the rise, with a growing number of studies 13 highlighting the complex role of the mitochondria in cell regulation (Picard, Wallace, and Burelle 14 2016; Sloan et al. 2018; Sprenger and Langer 2019) . Among these, numerous studies have found 15 that sequence variation in the mitochondrial DNA (mtDNA) can affect the expression of a range 16 of life-history and health related traits, from fertility, to longevity and thermal tolerance (Lajbner cells are enriched for mt-miRNAs encoded across multiple genes. Notably, the genes enriched for 1 mt-miRNAs in the mouse samples differed from those in the human HeLa cell lines, with mt-2 ATP8 the only mt-miRNA exhibiting high expression in the Ago2-IP samples of both species.
3
To better understand the differences and similarities in the results between human and 4 mouse samples, we performed a gene-by-by gene analysis of the transcriptional signature of the 5 mt-miRNAs across the mouse embryonic stem cells and HeLa cell lines (See SI Fig.S3-4 ).
6 Surprisingly, closer scrutiny of the putative mt-miRNA at mt-ATP8 in both species showed that 7 the mt-miRNA is only likely to exist in humans (Fig.3A) . In fact, while the human mt-ATP8 8 encodes an mt-miRNA (32nt long) with clear start and end, the same gene in mouse has only noise, 9 without any clear transcriptional signature presence. This suggests that the enrichment patterns of 10 the mt-miRNAs are accurate in predicting the presence of mt-miRNAs only when paired with 11 detailed analysis of the mt-miRNAs transcriptional signature. Furthermore, we identified unusual 12 transcriptional signatures that might shed light on some aspects of the biogenesis of the mt-13 miRNAs. Indeed, some mt-miRNAs are not fully encoded within a gene but overlap across two 14 different genes (Fig.3B ). We were able to identify this phenomenon only in the mouse samples, 15 where both mt-miRNA Phe and mt-miRNA Thr partially overlap with the neighbour gene (an 16 overlap of up to 6bp). Moreover, both of these mt-miRNAs have isoforms, "mt-isomiRs", similar 17 to observations in previous studies of nuclear miRNAs (Budak et al. 2016; Tan et al. 2014;  isomiRs, it is possible that the longer isoform may represent a transitional stage for the shorter 1 mature form. This phenomenon would be similar to what happens in piwi-interacting RNAs 2 (piRNAs), in which proteins located on the surface of the mitochondria edit the length of piRNAs 3 during their maturation process (Kim 2006; Nishimura et al. 2018; Ding et al. 2017; Bronkhorst 4 and Ketting 2018). While the mechanism underpinning the generation of these mt-isomiRs remains 5 unknown, our analysis provides the first report of mt-miRNAs encoded across the boundaries of 6 genes, and, in general, the presence of mitochondrial products encoded across genes. Mt-miRNAs and nuclear miRNAs have a different maturation process 8 Due to the presence of mt-isomiRs of different length, we investigated the possibility of 9 these RNAs representing transition stages of the mt-miRNA maturation process. To address this,
10
we re-purposed an RNA-seq dataset used for a study of the renal disease, Autosomal polycystic 11 kidney disease, which includes several kidney samples from transgenic mice (Woo et al. 2017 ).
12
The analysed dataset contains RNA samples in which the researchers had extracted both small and 13 long RNAs, separately from the same individual mice (Woo et al. 2017) . By comparing the 14 transcriptional signature of small and long RNAs in the same samples, we can screen for the 15 presence of matching transcriptional signatures, to determine whether either the start or end of 16 each mt-miRNA matches with the expression of a mt-long RNA. However, we did not identify 17 any matching transcriptional signatures between small and long RNAs (Fig.4 SI Fig.S5 ). The small 18 RNA samples show high levels of expression of mt-miRNAs in the mt-tRNAs Met and Ser 1, 19 while the long RNAs samples have no distinct transcriptional hotspots. In fact, although most 20 biological replicates of the long RNAs samples have a similar pattern of expression, we were not 21 able to identify any signal suggesting the presence of functional RNAs. Thus, we argue that the 22 consistent noisy pattern present in the long RNAs samples is most likely explained by the different chemical properties of the sequences, which would lead to some parts of the sequence being 1 slightly overrepresented than others (Ross et al. 2013) . On the contrary, the small RNA dataset 2 exhibited a pattern concordant with the expression of mt-miRNAs: ~30nt sequences with clear cut 3 start and end positions, consistent across multiple biological replicates (SI Fig S5) . Thus our results
4
suggest that the mt-miRNAs are not processed from pre-mt-miRNAs, as previously suggested, but 5 are more likely to be matured directly from the polycistronic mt-RNA (Mercer et al. 2011; 6 Rorbach and Minczuk 2012) from which mt-tRNAs and mt-rRNAs are matured. Mt-miRNAMet is conserved across Chordata.
8
Nuclear miRNAs are usually conserved across species (Kenny et al. 2015; Lee, Risom, and 9 Strauss 2007), and we investigated whether mt-miRNAMet, which is conserved in both human and 10 mouse (Fig. 1, 4) , would be conserved in other model organisms. Thus, we analysed the expression 11 and primary sequence of mt-miRNAMet across two tissues of four model organisms and verified 12 its conservation in Chordata (Fig 5) . The four model organisms (human, mouse, chicken, and 13 zebrafish) show a very consistent transcriptional signature for the mt-miRNAMet across both brain 14 and liver samples (Fig 5A) . In fact, in all species the mt-miRNAMet 3' end is at the beginning of 15 the mt-tRNA Met gene, while the 5' end is ~32nt after. However, one of the tissues has a different 16 signature. Samples from the human liver exhibit a noisier transcriptional signature, suggesting that 17 despite its broad conservation, this mt-miRNA might not be ubiquitously expressed across all 18 tissues. Indeed, this result aligns with one of our previous findings in mouse, as we did not find 19 the mt-miRNAMet in mouse embryonic stem cells, either transcribed or bound to Ago2. Similarly, 20 to the transcriptional signature, we found that the primary sequence of the mt-miRNAMet was 21 highly conserved across the four model organisms (Fig 5B) . The mt-miRNAMet sequence is almost 22 identical in all species, having only one polymorphism in amniotes, and four in zebrafish. When comparing the number of polymorphisms in the mt-miRNAMet to the polymorphisms in the rest of 1 the mt-tRNA Met, we found that the polymorphisms are underrepresented in the mt-miRNAMet. In 2 fact, in human, mouse and chicken there are around 4 times more mutations in the rest of the mt-3 tRNAMet compared to the mt-miRNAMet (1/30 against 5/39), while in zebrafish there are around 2 4 times more (4/30 against 10/39). This suggests that the region harbouring the mt-miRNAMet 5 might be under stronger purifying selection than its counterpart, which might be explained by the 6 presence of overlapping selection due to the dual role of these regions in encoding both mt-7 miRNAMet and mt-tRNA Met.
The mt-miRNAMet targets CFLAR in human temporal lobe 9 We investigated the function of the very conserved mt-miRNA, mt-miRNAMet, by 10 verifying the presence of target mRNAs in the most well-characterized species, humans. To 11 investigate the targets of mt-miRNAMet, we screened all 67087 human transcripts using a 12 computational target predictor, which found 8709 potential targets (Fig 6A) . These targets have 13 different scores, as some of them are more likely to be a genuine target compared to the others. 14 However, since it is impossible to establish a fully objective threshold, we filtered these potential 15 targets for a specific function. Although probably this mt-miRNA target many transcripts, we 16 decided to focus on genes involved in insulin regulation, because this pathway is at the intersection 17 of many diseases in which mitochondrial mutations and nuclear miRNAs appear to be involved 18 (C. Lee et al. 2015; Mohlke et al. 2005; Chalkia et al. 2018; Duarte, Palmeira, and Rolo 2015; 19 Heni et al. 2015) . By filtering for insulin regulation, we identified 74 transcripts. These transcripts 20 were then validated by using brain Ago2-IP samples enriched in miRNAs targets (Fig 6B) . These 21 brain samples are an ideal tissue to study the presence of these targets, given that mitochondrial 22 mutations are related to many neurodegenerative diseases (Takasaki 2009; Dölle et al. 2016) .
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Through this analysis we were able to validate one of the transcripts of the gene CASP8 and 1 FADD-like apoptosis regulator (CFLAR), which, as the name suggests, is a key protein in the 2 regulation of a caspase (CASP8) involved in the apoptosis pathway. However, as the mt-3 miRNAMet might not be the only miRNA binding this region, we verified how many nuclear 4 miRNAs are able to bind the same region. By using programs for in silico prediction of miRNA 5 targets in humans, we found that 13 nuclear miRNAs can bind the same region (Fig 6C) . 6 Nonetheless, by analysing other Ago2-IP samples from a similar part of the brain we found that 7 none of these nuclear miRNAs are expressed in brain tissue, while the mt-miRNAMet is present 8 (Fig 6D) . To verify that the absence of these miRNAs was not due to technical mistakes, or bias 9 of the library, we analysed three other common miRNAs (let-7, mir9, and mir100) finding that 10 they are expressed in the brain, and in some instances, at a similar expression level to the mt-11 miRNAMet. This analysis thus confirms that mt-miRNAMet binds to the CFLAR UTR.
12
To better understand the function of mt-miRNAMet, we investigated the function and 13 evolution of its target, CFLAR. By comparing the CFLAR genomic region across six primates 14 with high-level nuclear genome sequencing, we found that the human CFLAR has a unique 15 structure that might be related to the presence of the binding site of mt-miRNAMet (Fig7A). Indeed,
16
the binding site of mt-miRNAMet is near the end of the 12kb 3' UTR of CFLAR. This is puzzling 17 given the human CFLAR transcript consists of ~2kb of protein-coding sequence and its UTR is 6 18 times longer than the coding region. Furthermore, this UTR is not present in the transcript of any 19 other species, and it is absent from the CFLAR gene of other primates. However, a sequence of 20 12kb length is unlikely to be absent from closely related species, thus we expanded our Fig.S6 ). This evidence suggests that the 12kb UTR of CFLAR is conserved and transcribed 1 only in humans, thus its regulation by mt-miRNAMet is probably possible only in humans.
2
Discussion
3
The mtDNA is involved in RNA interference.
4
Our study confirmed the presence of two shared features of nuclear miRNAs and mt-5 miRNAs, suggesting a role for the mtDNA in RNAi. The first shared feature is the ability to bind 6 to Ago2. We provided definitive evidence that the mt-miRNAs can bind Ago2, the key protein in 7 gene regulation through RNAi. Although we found some noise in the Ago2-IP samples, the genes 8 having clearly defined mt-miRNAs were strongly upregulated in the comparison between Ago2-9 IP and mock-IP, thus supporting a genuine binding of these RNAs to Ago2. We verified the 10 consistent presence of mt-miRNAs binding to Ago2 across multiple independent studies,
11
suggesting that technical differences in RNA preparation, or sequencing, did not significantly However, as a preliminary investigation of this phenomena, we used a mix of computational and 14 experimental data to identify bone fide targets of the mt-miRNA that are most likely to be 15 functional.
16
The mt-miRNAMet -the selfish miRNA? 17 By investigating whether the mt-miRNAMet targets any mRNA in the human brain, we 18 uncovered evidence that mt-miRNA might be involved in the protection of mitochondria from 19 apoptosis. We identified strong evidence that CFLAR is a target of mt-miRNAMet. CFLAR is a 20 pseudo-caspase with multiple alternative transcripts known for having anti-apoptotic effect (S. A. hypothesize that this mt-miRNA might be protecting mitochondrial fitness at cellular level, thus 13 being the first "selfish miRNA", a miRNA expressed from an organelle which "protects" its own 14 genome from a cellular mechanism.
15
The mt-miRNAMet is involved in a human-specific regulation pathway 16 Our results suggest that the regulation of CFLAR by mt-miRNAMet is probably unique to humans and mice, which although express the same protein, do not share the same regulatory 6 region (Irmler et al. 1997; Shu, Halpin, and Goeddel 1997; Micheau et al. 2002) . Indeed, mouse, 7 like all other species, do not possess the 12kb UTR. Therefore, experiments on CFLAR function 8 have conflicting results across humans and mice most likely due to the presence of species-specific 9 regulation, such mt-miRNAMet as in humans, supporting the finding that mt-miRNAMet is part of a 10 human-specific pathway.
11
Are the mt-miRNAs acting outside the mitochondria? 12 Notwithstanding the ability of the mt-miRNAs to bind Ago2, their function is expected to 13 be exerted outside the mitochondria. However, the mechanism that would lead the mt-miRNAs 14 out of the mitochondria and into the cytoplasm remains unknown. The ability to bind Ago2 15 suggests the ability of mt-miRNAs to translocate outside to reach the protein, most likely using 16 the same, yet not fully characterized, transport mechanism used by other nucleic acids. Indeed, and short mt-RNAs found no support for this precursor hypothesis, due to the lack of longer RNAs 6 in the mt-tRNA Thr. We suggest this RNA might be associated with a different function from 7 canonical miRNAs. Indeed, in studies using Ago2-IP samples, the RNAs of ~35 length are usually 8 considered fragments of miRNA targets, such as mRNAs, and not miRNAs (Boudreau et al. 2014 ).
9
The hypothesis that the mt-tRNA Thr might be a target of Ago2 is supported by our analysis of 10 mt-miRNAs in RNA-seq samples without Ago2-IP treatment in mouse. In these samples, we found 
20
Multiple gene layers in the mitochondria. 21 Our study shows that the mtDNA harbours multiple gene layers, and that the products of 
19
The mt-miRNAs change our perspective on mitonuclear interactions.
20
The mt-miRNAs add another level of complexity to the dynamics of mitonuclear However, the mechanisms underpinning these diverse effects associated with the mitochondrial 12 genome are yet to be understood. We believe that RNAi, mediated through mt-miRNAs, might 13 well provide the explanation for the diversity of phenotypic effects associated with mitochondrial 14 sequence variation.
15
The unusual maturation of the mt-miRNAs.
16
The mitochondria generally transcribe long mt-RNA precursors encoding multiple genes 2017), our results suggest that the mt-miRNAs originate from the pre-mt-RNAs. Indeed, we 1 identified multiple cases of specific isoforms of mt-miRNAs whose sequence spanned two genes.
2
In these cases, it is clear that miRNAs cannot originate from a mature tRNA, since they would 
13
Overlapping selection.
14 Mitochondrial genes are known to be under constant strong purifying selection (J. W. (Rogozin et al. 2002) . We hypothesise that the presence of overlapping genes such as 20 mt-miRNAs and dsRNAs (Dhir et al. 2018) , on canonical genes such as mt-tRNAs, will increase 21 the effect of purifying selection in order to preserve the function of these products. Our results
22
support this hypothesis, showing that within the mt-tRNA Met, the region harbouring the mt-miRNAMet has fewer polymorphisms than did the rest of the tRNA gene. While more analysis 1 across a broad number of species and mt-miRNAs will be necessary to fully test this hypothesis, 2 this study provides the first evidence that this phenomenon might exist. 
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and request about the reagents can be directed to the Lead Contact, Andrea Pozzi (andreapozzi.a@gmail.com). However, as the data are sourced from previously published articles, we can only redirect you to the appropriate source, and we cannot personally provide full details of each reagent.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
This study is based on published data deposited in the Sequence Read Archive (SRA) in NCBI, thus all information listed here are sourced from the original study where the data were obtained.
Cell lines
According to the original authors (Zhang et al., 2018) , HeLa cells were grown on 15 cm plates using MEDM plus 10% FBS. The neuronal progenitor (NP) and teratoma-derived fibroblast (TDF) cell culture, were derived from human embryonic stem cells (hESC). The differentiation of hESC into NP was induced by replacing the original growing medium with DMEM/F12 supplemented with 2% B27, 100ng/ml FGF, 100ng/ml EGF and 5ng/ml heparin. Further details on the methods can be found at GSE115146 in the Gene Expression Omnibus (GEO) database and in the original article.
The differentiation of hESC into TDF was induced by injection of resuspended cells into mice homozygous for severe combined immune deficiency spontaneous mutation (SCID). The tumors grew in after 6 weeks were then removed and cultured in a medium of 10% FBS, nonessential amino acids, 2mM glutamine, 1% penicillin/streptomycin and 0.55μM β-mercaptoethanol. Further details on the methods, as described by the original authors, can be found at GSE112006 in the Gene Expression Omnibus (GEO) database.
According to the original authors (Zamudio et al., 2014) , the embryonic stem cell culture (mESC) were grown on gelatinized tissue culture plates in Dulbecco's Modified Essential Media supplemented with multiple other nutrients. The full list of nutrients and details about the growing method can be found at GSE50595 in the GEO database and in the original article.
Model organisms
According to the original authors (Jee et al., 2018; Viljetic et al., 2017) , the experiments on mice sourced from the Jackson laboratory were carried out in compliance with their institutional protocols, thus we believe that correct ethics for the experiments have been followed.
According to the original authors (Woo et al., 2017) , the experiments on mice sourced by Stefan Somlo were carried out in compliance with the Animal Care and Use Committee (IACUC) rules at Sookmyung Women's University. Therefore, we believe that correct ethics were followed during the experiment.
According to the original authors, the samples from the chickens were sourced by Peter Jensen, however, there is not any further details about how the chickens were housed and maintained.
According to the original authors (Vaz et al., 2015) , the zebrafish (Singapore strain) were maintained according to the Animal Care and Use Committee (IACUC) rules. Therefore, we believe that correct ethics were followed during the experiment.
Human samples
The BA9 samples were obtained by the original authors (Hoss et al., 2015) , and the gathering of the samples were exempt from ethics approval because the study involves only tissue collected post-mortem, and consequently not classified as human subjects. This decision was taken by the Boston University School of Medicine Institutional Review Board (Protocol H-28974).
The CHC samples were obtained by the original authors (Butt et al., 2016) , and the original authors declared that written informed consent for the use of biological samples and clinical records was given by all the participants. Furthermore, they declared that their work was done in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and the International Conference on Harmonization Guidelines for Good Clinical Practice.
The TL samples were obtained by the original authors (Maragkakis et al., 2016; Nakaya et al., 2013) , and the authors provided only a brief description of the samples. Indeed, they only mention that the samples come from temporal surgical lobectomy of three unrelated individuals. Although no statements on ethics is present in the original articles, we believe that is likely that the correct ethics approval processes are followed in the institution where the experiments where performed (University of Pennsylvania).
METHOD DETAILS Ago2 co-immunoprecipitation sequencing
According to the original authors (Zhang et al., 2018) , before the Ago2 immunoprecipitation (IP) of HeLa cells, the cultures were UV irradiated at 400mj. The IP was performed using Anti-Ago2 (Abnova, H00027161-M01), and following the IP the RNA libraries were made and sequenced using Hi-Seq 2500. Further details can be found in the original article and in the GEO database (GSE115146).
According to the original authors, before the Ago2-IP of the NP and TDF, the cultures were UV irradiated at 400mj. The IP was performed using Anti-Ago2 (ProteinTech) and following the IP the RNA libraries were made and sequenced using Hi-Seq 2000. Further details can be found in the GEO database (GSE112006).
According to the original authors (Zamudio et al., 2014) , the mESC cells have been modified to leave only a modified Ago2 active in these cells. This modified Ago2 gene is known as FLAGhemagglutinin (HA)-tagged hAgo2 (FHAgo2), thus has a specific epitope that can be targeted for IP. Furthermore, contrary to the experiments in other cell lines, in this case the cell cultures were lysed before the UV-cross linking and IP. Further details can be found in the original article and in the GEO database (GSE50595).
The Ago2-IP of the TL samples were performed using 2A8 Anti-Ago monoclonal antibody tethered to Protein A Dynabeads (Invitrogen), according to the original authors (Maragkakis et al., 2016) . Further details can be found in the original article and in the BioProject NCBI database (PRJNA299324).
Ago2 immunoprecipitation miRNA targets enrichment
The original authors of the study performed the mRNA target enrichment (Maragkakis et al., 2016) , and we describe here a short summary of their method. After the Ago2-IP of the three brain samples, the authors isolated longer RNAs (miRNA targets) using nitrocellulose filter, and 8% PAGE gels. Once the targets were purified, they have been re-amplified by PCR and sequenced. Further information about the methods can be found in previous works of the authors (Maragkakis et al., 2016; Nakaya et al., 2013) .
Mt-miRNAs sequence alignment
The alignment of the RNA-seq libraries, both with and without IP, were performed using BowTie2 (Langmead & Salzberg, 2013) . We did not remove the adapter for each library, and instead used the soft clipping provided by bowtie2 through the setting --local. Due to the possible differences between the reference genome used, and the sequence of the individual used for analysis, we used non-stringent parameters in the alignment. Thus, for the alignment we set a seed of 20 nucleotides (-L 20) and we allowed up to 1 mismatch (-N 1) between the small RNA and the reference genome. To gauge the overall amount of small RNAs within one gene, we used samtools idxstats function (Li et al., 2009) , which outputs the reads aligning to each chromosome. Likewise, to obtain the coverage for each nucleotide, and thus identify the mitochondrial genes having the transcriptional signature of a mt-miRNA, we used the function genomecov of bedtools (Quinlan & Hall, 2010) . To generate the total coverage for each gene, we used the setting genomecov -d -i while for the 5' and 3' coverage we added the setting -5 and -3 respectively. To generate the correct format to plot the gene coverage in the R package circlize, we used the parameter -bg instead of -d on bedtools genomecov. The alignment was done using the current reference genomes for human (NC_012920.1) and mouse (NC_005089.1).
Mt-miRNAMet polymorphism identification
The identification of polymorphism on the mt-miRNAMet across multiple species was performed by visual comparison of the sequences downloaded from the mt-tRNAs database mitotRNAdb (http://mttrna.bioinf.uni-leipzig.de/mtDataOutput/Welcome). We only used the reference sequences to establish the presence of polymorphisms, and we did not include any population data, because the quality of population data (i.e. the frequency of specific polymorphisms) are very different across the organisms considered. Therefore, we used the reference genome present in mitotRNAdb for Danio rerio (NC_002333.2), Gallus gallus (NC_001323.1), Homo sapiens (NC_012920.1), and Mus musculus (NC_005089.1).
Mt-miRNAMet target prediction
The in silico prediction of the mt-miRNAMet target was done using the web-server MR-microT (Kanellos et al., 2014; Reczko et al., 2012) , a program able to use a custom miRNA sequence to identify potential target mRNAs in the human genome (using the database Ensembl v84). This program outputs both a score, indicating how likely is the predicted target to be real, and the regions of the sequence where miRNA and mRNAs are predicted to interact. As mentioned in the results, the list of potential targets predicted by this program is 8,709, which we filtered using the gene ontology (GO) term Insulin Response (GO:0032869) to obtain a list of 74 potential targets. To experimentally verify these targets, we extracted the coverage of each gene using bedtools (Quinlan & Hall, 2010) with settings genomecov -d -i , and then inspected by eye for the presence of sequences in the regions corresponding to the prediction of MR-micro T. Although this method might be missing several targets of this gene (false negative), we focused on finding targets that have the highest chance of being real (true positive). It is worth noting that the mRNA target identified using this method, CFLAR, has a MR-micro T score with high likelihood to be predictive (>0.8) according to the authors of the program (Kanellos et al., 2014; Reczko et al., 2012) .
Comparative analysis mt-miRNAMet and nuclear miRNAs
The miRNAs were quantified using the output of samtools flagstat option, which provides the number of aligned reads, both the total amount and as a percentage of the RNA pool, for the specified reference sequence. We used mt-tRNA Met as the reference sequence to quantify the amount of mt-miRNA Met reads expressed, indeed, over 90% of the reads come from the region of the mt-miRNAMet, thus using the coverage of the entire mt-tRNA Met provides a very good approximation of mt-miRNAMet without excluding any of its isoforms. To identify miRNAs that might be binding the same regions as mt-miRNAMet, we used TargetscanHuman 7.2 (http://www.targetscan.org/) using CFLAR as a query, and then we annotated all the miRNAs predicted to bind the same, or similar, positions of mt-miRNAMet. Using this approach, we annotated 13 miRNAs: hsa-miR-6747-3p, hsa-miR-6778-3p, hsa-miR-150-5p, hsa-miR-186-3p, hsa-miR-4698, hsa-miR-4731-5p, hsa-miR-5589-5p, hsa-miR-6506-5p, hsa-miR-619-5p, hsamiR-5089-5p, hsa-miR-6504-3p, hsa-miR-4438, hsa-miR-5095, hsa-miR-7151-3p. To quantify the nuclear miRNAs, we used the sequences present in miRBase (http://www.mirbase.org/) as a reference sequence for samtools. However, none of these nuclear miRNAs was found in brain tissues. To verify the absence of artifacts, or errors in our analysis, we used the same method to quantify common, well-known miRNAs. The miRNAs we chose are hsa-Let7a-1, hsa-miR-9-5p, hsa-miR-100. The similar abundance of these miRNAs to the mt-miRNAMet confirmed the likely we extracted only the ones involved in insulin response, a mechanism key in many mitochondria-related diseases. We then experimentally validated these targets by using an Ago2-IP dataset. B) We experimentally validated the binding between Ago2 and CFLAR by analyzing a dataset composed of three independent brain tissue samples. In this dataset Ago2 has been cross-linked to target mRNAs, and these RNAs have been isolated by size selection in gel. We show the high coverage present in the region predicted to bind mt-miRNAMet on the CFLAR 3' UTR across three biological replicates. The X-and Y-axes represent the positions within the 3' UTR of CFLAR and the abundance of reads. C) a schematic representation of the binding of mt-miRNAMet and the CFLAR nuclear miRNAs, a group of miRNAs predicted to bind this region of CFLAR in humans. A list of these miRNAs is present on the side of the figure, using the nomenclature present on miRBase. D) The boxplot represents the expression of four miRNAs, and a group of miRNAs named here CFLAR miRNAs. The expression is represented as the percentage representation of a given miRNA relative to the entire pool of miRNAs. Due to the absence of all the CFLAR miRNAs, we represented them as one group of pooled miRNAs (CFLAR miRNA). The presence of let-7, mir9, and mi100 to highlight that common miRNAs are expressed in a comparable way to mt-miRNAMet in the brain samples that we analyzed. showing that the ~12kb UTR present in humans is not translated anymore in primates but can be found at a short distance from the CFLAR gene (between 1 and 5 kb). No other miRNAs bind the CFLAR region bound by mt-miRNAMet. To see more details about the alignment of the genomic region of CFLAR between humans and other primates see Figure S6 .
